HiDO Technologies
CompanyUnited States
HiDO Technologies develops 2 assets, the furthest in phase 2 (HiDO-ALZ in Alzheimer's disease). Mostly device; based in the United States.
- 2
- Assets
- Furthest stage
- Phase 2
- 2
- Trials
- 3
- Signals
Pipeline
2Automated medication dispenser with facial recognition and video observation to ensure adherence.
Phase 2, Device, Alzheimer's disease, dementia
Automates medication dispensing, monitors medication use, and alerts caregivers to support medication adherence.
Human trials, Device, Alzheimer's disease and related dementias, dementia
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Trials2
- Signals3
- Similar companies6